India Gene Therapy Market to Grow with a CAGR of 16.83% through 2030
Rising
investment in biotechnology is expected to drive the India Gene Therapy Market
growth in the forecast period, 2026-2030.
According to
TechSci Research report, “India Gene Therapy Market - By Region, Competition, Forecast & Opportunities, 2030F”, the India Gene Therapy
Market stood at USD 472.24 Million in 2024 and is anticipated to grow with a
CAGR of 16.83% through 2030. The
Indian government has implemented several initiatives to foster the growth of
the gene therapy market, aiming to position the country as a leader in
biotechnology and advanced healthcare solutions. One of the key initiatives is
the National Biotechnology Development Strategy (NBDS), which focuses on
advancing biotechnology through enhanced research and innovation. This strategy
includes support for gene therapies, with an emphasis on developing treatments
for genetic disorders and rare diseases.
In
addition, the Department of Biotechnology (DBT) has been instrumental in
funding and promoting gene therapy research through schemes like the
Biotechnology Ignition Grant (BIG) and Biotechnology Industry Research
Assistance Council (BIRAC). These initiatives offer financial assistance,
mentorship, and networking opportunities for biotech startups, enabling them to
bring innovative gene therapies to market. The government also collaborates
with international organizations and private companies to boost research in
gene-based treatments, ensuring access to the latest technologies and
expertise.
Rising
Investment in Biotechnology is a significant trend shaping the Indian market, particularly
in the field of gene therapy. With the increasing focus on developing
innovative healthcare solutions, India is witnessing a surge in both public and
private sector investments in biotechnology. These investments are directed
towards research and development (R&D), infrastructure, and talent
acquisition, all of which are crucial for the advancement of gene-based
therapies.
India’s
biotechnology sector has attracted global attention due to its growing
capabilities in genetic research, cell and gene therapy, and biomanufacturing.
Major pharmaceutical companies, as well as startups, are investing heavily in
genetic research, aiming to develop treatments for rare and chronic diseases
like Sickle Cell Disease, Hemophilia, and Spinal Muscular Atrophy. This trend
is further supported by government initiatives, such as the Biotechnology
Industry Research Assistance Council (BIRAC), which facilitates funding and
policy support for biotech innovations.
Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "India Gene Therapy Market”
The India Gene
Therapy Market is segmented into indication, vector type, route of
administration, regional distribution, and company.
Based
on Route of Administration, Intravenous emerged as the dominating segment
in the India Gene Therapy Market in 2024. This is due to its ease of use, wide acceptance,
and ability to deliver gene therapies effectively across a variety of diseases.
IV administration allows for direct delivery of gene therapy vectors into the
bloodstream, ensuring quick circulation throughout the body and reaching
targeted tissues, such as the liver, muscle, or bone marrow, where they exert
therapeutic effects.
Based
on Region, South India emerged as the fastest growing region in the India
Gene Therapy Market in 2024. This growth can be attributed to several factors,
including the presence of leading biotech hubs in cities like Bengaluru,
Hyderabad, and Chennai, which are home to numerous research institutions,
pharmaceutical companies, and clinical trial centers. The region has seen
significant investment in healthcare infrastructure, biotechnology R&D, and
skilled workforce development, which has boosted the adoption and development
of gene therapies. Moreover, South India’s growing healthcare needs, rising
awareness about genetic disorders, and the increasing prevalence of conditions
like Sickle Cell Disease (SCD) and Spinal Muscular Atrophy (SMA) have created a
favorable environment for gene therapy innovation.
Major companies
operating in India Gene Therapy Market are:
- Novartis
India Ltd.
- Bharat
Biotech
- Cipla Limited
- Zydus
Group
- Biocon
Limited
- Dr.
Reddy's Laboratories
- Intas
Pharmaceuticals Ltd.
- Sun
Pharmaceutical Industries Ltd.
- Serum
Institute of India
- Panacea
Biotec
Download Free Sample Report
Customers can
also request for 10% free customization on this report
“The cost of gene therapy in India has been steadily
reducing due to advancements in manufacturing processes and the local
production of therapy products, making these treatments more accessible to the
broader population. Traditionally, gene therapies were highly expensive, often
costing millions of dollars per treatment, largely due to the complex and
resource-intensive nature of their production, which involved reliance on
imported materials and global manufacturers”, said Mr. Karan Chechi, Research
Director of TechSci Research, a research-based management consulting firm.
“India Gene Therapy
Market By Indication (Large B-Cell Lymphoma, Multiple Myeloma, Spinal Muscular
Atrophy (SMA), Acute Lymphoblastic Leukemia (ALL), Melanoma (lesions),
Inherited Retinal Disease, Beta-Thalassemia Major/SCD, Others), By Vector Type
(Lentivirus, RetroVirus & gamma RetroVirus, AAV, Modified Herpes Simplex
Virus, Adenovirus, Others), By Route of Administration (Intravenous, Others),
By Region, Competition, Forecast & Opportunities, 2020-2030F”,
has evaluated the future growth potential of India Gene Therapy Market and
provides statistics & information on market size, structure, and future
market growth. The report intends to provide cutting-edge market intelligence
and help decision makers take sound investment decisions. Besides, the report
also identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in India Gene Therapy Market.
Contact
TechSci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel: +1-332-258-6602
Email: sales@techsciresearch.com
Website: www.techsciresearch.com